Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A16820 | 28153707 | Biochim Biophys Acta Mol Basis Dis | Interleukin-17A exacerbates high-fat diet-induced hepatic steatosis by inhibiting fatty acid β-oxidation. | 2017 | Details |
| A16821 | 28152105 | PLoS One | Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort. | 2017 | Details |
| A16822 | 28149843 | Ann Transl Med | Gamma-glutamyl transferase and cardiovascular disease. | 2016 | Details |
| A16823 | 28149317 | ARYA Atheroscler | Prevalence of non-alcoholic fatty liver disease in patients with coronary artery disease. | 2016 | Details |
| A16824 | 28148637 | J Pharmacol Exp Ther | Impact of Nonalcoholic Fatty Liver Disease on Toxicokinetics of Tetrachloroethylene in Mice. | 2017 | Details |
| A16825 | 28146130 | Nutrients | Effects of Natural Products on Fructose-Induced Nonalcoholic Fatty Liver Disease (NAFLD). | 2017 | Details |
| A16826 | 28144390 | World J Hepatol | Predictors for advanced fibrosis in morbidly obese non-alcoholic fatty liver patients. | 2017 | Details |
| A16827 | 28144388 | World J Hepatol | Hepatic structural enhancement and insulin resistance amelioration due to AT1 receptor blockade. | 2017 | Details |
| A16828 | 28144387 | World J Hepatol | From the liver to the heart: Cardiac dysfunction in obese children with non-alcoholic fatty liver disease. | 2017 | Details |
| A16829 | 28143996 | Acta Med Indones | The Role of Probiotic in Reducing Hepatic Inflammation Among NAFLD Patients: an Evidence-based Case Report. | 2016 | Details |
| A16830 | 28142230 | Korean J Intern Med | Compound K attenuates glucose intolerance and hepatic steatosis through AMPK-dependent pathways in type 2 diabetic OLETF rats. | 2017 | Details |
| A16831 | 28142119 | Biomed Pharmacother | Ginkgolide A ameliorates non-alcoholic fatty liver diseases on high fat diet mice. | 2017 | Details |
| A16832 | 28139562 | Ter Arkh | [The informative value of non-invasive liver fibrosis markers in patients with nonalcoholic fatty liver disease]. | 2017 | Details |
| A16833 | 28139281 | Clin Nutr | Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids. | 2017 | Details |
| A16834 | 28139128 | Vnitr Lek | [Coffee as hepatoprotective factor]. | 2017 | Details |
| A16835 | 28138308 | Int J Med Sci | Steatosis influences the clinical profiles and long-term outcomes of interferon-treated chronic hepatitis C and liver cirrhosis patients. | 2017 | Details |
| A16836 | 28138103 | Clin Sci (Lond) | Turning up the heat against metabolic syndrome and non-alcoholic fatty liver disease. | 2017 | Details |
| A16837 | 28134852 | Int J Mol Sci | Metabolomic Fingerprinting in the Comprehensive Study of Liver Changes Associated with Onion Supplementation in Hypercholesterolemic Wistar Rats. | 2017 | Details |
| A16838 | 28134687 | Curr Opin Gastroenterol | Fecal microbiota transplantation for gastrointestinal disorders. | 2017 | Details |
| A16839 | 28133993 | Appl Physiol Nutr Metab | A "healthy diet-optimal sleep" lifestyle pattern is inversely associated with liver stiffness and insulin resistance in patients with nonalcoholic fatty liver disease. | 2016 | Details |
| A16840 | 28133774 | Hepatology | Dual-photon microscopy-based quantitation of fibrosis-related parameters (q-FP) to model disease progression in steatohepatitis. | 2017 | Details |
| A16841 | 28133479 | Gastroenterol Res Pract | Metformin and Diammonium Glycyrrhizinate Enteric-Coated Capsule versus Metformin Alone versus Diammonium Glycyrrhizinate Enteric-Coated Capsule Alone in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus. | 2017 | Details |
| A16842 | 28132890 | Gastroenterology | Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis. | 2017 | Details |
| A16843 | 28132721 | Immunobiology | Hepatic interleukin-6 production is maintained during endotoxin tolerance and facilitates lipid accumulation. | 2017 | Details |
| A16844 | 28131861 | Toxicology | Alcoholic fatty liver is enhanced in CYP2A5 knockout mice: The role of the PPARα-FGF21 axis. | 2017 | Details |
| A16845 | 30539079 | Sports Med Int Open | Simple Resistance Exercise for 24 Weeks Decreases Alanine Aminotransferase Levels in Patients with Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A16846 | 28130788 | Hepatology | Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis. | 2017 | Details |
| A16847 | 28128372 | Food Funct | The hepatoprotective effect of Phyllanthus emblica L. fruit on high fat diet-induced non-alcoholic fatty liver disease (NAFLD) in SD rats. | 2017 | Details |
| A16848 | 28128316 | Sci Rep | Six-year changes in the prevalence of obesity and obesity-related diseases in Northeastern China from 2007 to 2013. | 2017 | Details |
| A16849 | 28127545 | Can J Gastroenterol Hepatol | Advanced Hepatic Fibrosis in Fatty Liver Disease Linked to Hyperplastic Colonic Polyp. | 2017 | Details |
| A16850 | 28127199 | World J Gastroenterol | Mitochondrial carnitine palmitoyl transferase-II inactivity aggravates lipid accumulation in rat hepatocarcinogenesis. | 2017 | Details |
| A16851 | 28127194 | World J Gastroenterol | Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease. | 2017 | Details |
| A16852 | 28126503 | Presse Med | [Pathophysiology of obstructive sleep apnea syndrome and its cardiometabolic consequences]. | 2017 | Details |
| A16854 | 28125672 | PLoS One | Relationship of Serum Betatrophin with Nonalcoholic Fatty Liver in a Chinese Population. | 2017 | Details |
| A16855 | 28125073 | Clin Transl Gastroenterol | The Association Between IGF-1 Levels and the Histologic Severity of Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16856 | 28125040 | Molecules | Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years. | 2017 | Details |
| A16857 | 28124507 | Obesity (Silver Spring) | Fatty liver promotes fibrosis in monkeys consuming high fructose. | 2017 | Details |
| A16861 | 28123944 | Mol Metab | Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1. | 2016 | Details |
| A16862 | 28123936 | Mol Metab | Metabolomic profiling identifies potential pathways involved in the interaction of iron homeostasis with glucose metabolism. | 2016 | Details |
| A16863 | 28123933 | Mol Metab | A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism. | 2016 | Details |
| A16864 | 28123443 | Hepat Mon | Liver Illness and Psychiatric Patients. | 2016 | Details |
| A16865 | 28123441 | Hepat Mon | Liver Mitochondrial DNA Copy Number and Deletion Levels May Contribute to Nonalcoholic Fatty Liver Disease Susceptibility. | 2016 | Details |
| A16866 | 28120721 | Curr Pharm Des | Progranulin, a New Adipokine at the Crossroads of Metabolic Syndrome, Diabetes, Dyslipidemia and Hypertension. | 2017 | Details |
| A16867 | 28120165 | J Inherit Metab Dis | Investigating the link of ACAD10 deficiency to type 2 diabetes mellitus. | 2017 | Details |
| A16868 | 28119530 | Int J Obes (Lond) | Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD. | 2017 | Details |
| A16869 | 28119261 | Hepatobiliary Pancreat Dis Int | Roles of microRNAs in immunopathogenesis of non-alcoholic fatty liver disease revealed by integrated analysis of microRNA and mRNA expression profiles. | 2017 | Details |
| A16870 | 28116873 | Endocrinol Metab (Seoul) | The SCAP/SREBP Pathway: A Mediator of Hepatic Steatosis. | 2017 | Details |
| A16871 | 28116801 | Aliment Pharmacol Ther | Assessment of treatment response in non-alcoholic steatohepatitis using advanced magnetic resonance imaging. | 2017 | Details |
| A16872 | 28116779 | Mol Nutr Food Res | Long-term dietary supplementation with low-dose nobiletin ameliorates hepatic steatosis, insulin resistance, and inflammation without altering fat mass in diet-induced obesity. | 2017 | Details |
| A16873 | 28116521 | Virchows Arch | In hepatic venous outflow obstruction, alcoholic liver disease, and nonalcoholic fatty liver disease, centrilobular scars, CD34+ vessels, and keratin 7+ hepatocytes are in close proximity. | 2017 | Details |
| A16874 | 28115925 | PPAR Res | PPARs and Mitochondrial Metabolism: From NAFLD to HCC. | 2016 | Details |
| A16875 | 28115795 | Mediators Inflamm | The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications. | 2017 | Details |
| A16876 | 28115523 | J Biol Chem | APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice. | 2017 | Details |
| A16877 | 28115335 | BMJ Open | Association between soil heavy metals and fatty liver disease in men in Taiwan: a cross sectional study. | 2017 | Details |
| A16878 | 28113242 | IEEE Trans Biomed Eng | A Novel Method for Continuous, Noninvasive, Cuff-Less Measurement of Blood Pressure: Evaluation in Patients With Nonalcoholic Fatty Liver Disease. | 2016 | Details |
| A16879 | 28112684 | J Clin Invest | Out of the frying pan: dietary saturated fat influences nonalcoholic fatty liver disease. | 2017 | Details |
| A16880 | 28112681 | J Clin Invest | Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance. | 2017 | Details |
| A16881 | 28112179 | Acta Pharmacol Sin | Dicer1/miR-29/HMGCR axis contributes to hepatic free cholesterol accumulation in mouse non-alcoholic steatohepatitis. | 2017 | Details |
| A16882 | 28112071 | J Dev Orig Health Dis | Early life programming and the risk of non-alcoholic fatty liver disease. | 2017 | Details |
| A16883 | 28111272 | Clin Chim Acta | The NAFL Risk Score: A simple scoring model to predict 4-y risk for non-alcoholic fatty liver. | 2017 | Details |
| A16884 | 28111263 | Pharmacol Res | An update on the assessment and management of metabolic syndrome, a growing medical emergency in paediatric populations. | 2017 | Details |
| A16885 | 28110314 | J Basic Clin Physiol Pharmacol | Long-term exposure to a butter-rich diet induces mild-to-moderate steatosis in Chang liver cells and Swiss albino mice models. | 2017 | Details |
| A16886 | 28110193 | Biomed Pharmacother | Effects of polyphenol compounds melanin on NAFLD/NASH prevention. | 2017 | Details |
| A16887 | 28110063 | Int Immunopharmacol | Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-κB translocation. | 2017 | Details |
| A16888 | 28109892 | Free Radic Biol Med | Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis. | 2017 | Details |
| A16889 | 28109166 | Br J Pharmacol | A novel dual amylin and calcitonin receptor agonist, KBP-089, induces weight loss through a reduction in fat, but not lean mass, while improving food preference. | 2017 | Details |
| A16890 | 28109099 | Nan Fang Yi Ke Da Xue Xue Bao | [Effect of Hugan Qingzhi tablets on AMPK pathway activation and NF-κB-p65 protein expression in the liver of rats with nonalcoholic fatty liver disease]. | 2017 | Details |
| A16891 | 28109005 | Hepatology | The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B. | 2017 | Details |
| A16892 | 28108233 | J Hepatol | Murine CD103+ dendritic cells protect against steatosis progression towards steatohepatitis. | 2017 | Details |
| A16893 | 28108035 | Vet Clin North Am Small Anim Pract | Feline Hepatic Lipidosis. | 2017 | Details |
| A16894 | 28107471 | PLoS One | High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments. | 2017 | Details |
| A16895 | 28107283 | J Pediatr Gastroenterol Nutr | NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). | 2017 | Details |
| A16896 | 28106941 | Liver Int | Serum apoB levels independently predict the development of non-alcoholic fatty liver disease: A 7-year prospective study. | 2017 | Details |
| A16897 | 28106137 | Sci Rep | Ameliorative effects of Compound K and ginsenoside Rh1 on non-alcoholic fatty liver disease in rats. | 2017 | Details |
| A16898 | 28105511 | Calcif Tissue Int | Bone Density in the Obese Child: Clinical Considerations and Diagnostic Challenges. | 2017 | Details |
| A16899 | 28104990 | World J Gastroenterol | Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial. | 2017 | Details |
| A16900 | 28104981 | World J Gastroenterol | Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier. | 2017 | Details |
| A16901 | 28103934 | Lipids Health Dis | The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease. | 2017 | Details |
| A16903 | 28103626 | Hepatology | Nonalcoholic fatty liver disease in adolescents and young adults: The next frontier in the epidemic. | 2017 | Details |
| A16904 | 28101773 | World J Pediatr | What is the appropriate strategy for diagnosing NAFLD using ultrasonography in obese children? | 2017 | Details |
| A16905 | 28101103 | Gastroenterol Res Pract | Albumin Binding Function: The Potential Earliest Indicator for Liver Function Damage. | 2016 | Details |
| A16906 | 28100771 | J Biol Chem | Janus Kinase 2 (JAK2) Dissociates Hepatosteatosis from Hepatocellular Carcinoma in Mice. | 2017 | Details |
| A16907 | 28100008 | Hepatology | Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review. | 2017 | Details |
| A16908 | 28099601 | An Bras Dermatol | Psoriasis comorbidities: complications and benefits of immunobiological treatment. | 2017 | Details |
| A16909 | 28099469 | PLoS One | The Prevalence of Nonalcoholic Fatty Liver Disease and Related Metabolic Comorbidities Was Associated with Age at Onset of Moderate to Severe Plaque Psoriasis: A Cross-Sectional Study. | 2017 | Details |
| A16910 | 28098910 | Mol Med Rep | Hydrogen-rich saline improves non‑alcoholic fatty liver disease by alleviating oxidative stress and activating hepatic PPARα and PPARγ. | 2017 | Details |
| A16911 | 28098838 | Molecules | Role of UDP-Glucuronosyltransferase 1A1 in the Metabolism and Pharmacokinetics of Silymarin Flavonolignans in Patients with HCV and NAFLD. | 2017 | Details |
| A16912 | 28098578 | J Clin Gastroenterol | Helicobacter pylori and Risk of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. | 2019 | Details |
| A16913 | 28097795 | Liver Int | Impaired N-linked glycosylation of uptake and efflux transporters in human non-alcoholic fatty liver disease. | 2017 | Details |
| A16914 | 28097097 | J Clin Transl Hepatol | miR-29a Promotes Lipid Droplet and Triglyceride Formation in HCV Infection by Inducing Expression of SREBP-1c and CAV1. | 2016 | Details |
| A16915 | 28095261 | Expert Rev Gastroenterol Hepatol | Serum alkaline phosphatase, a risk factor for non-alcoholic fatty liver, but only for women in their 30s and 40s: evidence from a large cohort study. | 2017 | Details |
| A16916 | 28094767 | J Clin Invest | Impaired SUMOylation of nuclear receptor LRH-1 promotes nonalcoholic fatty liver disease. | 2017 | Details |
| A16917 | 28092906 | Med Princ Pract | Association between Nicotinamide Phosphoribosyltransferase and de novo Lipogenesis in Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16918 | 28092655 | Nat Cell Biol | Circadian- and UPR-dependent control of CPEB4 mediates a translational response to counteract hepatic steatosis under ER stress. | 2017 | Details |
| A16919 | 28092182 | Exp Biol Med (Maywood) | An estrogen receptor β-selective agonist inhibits non-alcoholic steatohepatitis in preclinical models by regulating bile acid and xenobiotic receptors. | 2017 | Details |
| A16920 | 28091912 | Bull Exp Biol Med | Caspase 3, 6, 8, and 9 Gene Expression in Peripheral Blood Leukocytes and Plasma Concentrations of IL-6 and TNF-α in Carriers of Different Polymorphic Marker -174G>C Genotypes of IL6 Gene Associated with the Risk of Nonalcoholic Steatohepatitis. | 2017 | Details |
| A16923 | 28090564 | Cell Mol Gastroenterol Hepatol | Hepatocyte Toll-Like Receptor 5 Promotes Bacterial Clearance and Protects Mice Against High-Fat Diet-Induced Liver Disease. | 2016 | Details |
| A16924 | 28089627 | Clin Breast Cancer | The Relationship Between Tamoxifen-associated Nonalcoholic Fatty Liver Disease and the Prognosis of Patients With Early-stage Breast Cancer. | 2016 | Details |
| A16925 | 28089623 | Dig Liver Dis | Which treatment for type 2 diabetes associated with non-alcoholic fatty liver disease? | 2016 | Details |
| A16926 | 28089502 | Diabetes Metab | An extended fatty liver index to predict non-alcoholic fatty liver disease. | 2017 | Details |